AU Patent

AU2018312328A1 — Carbamoyl phenylalaninol analogs and uses thereof

Assigned to Jazz Pharmaceuticals Ireland Ltd · Expires 2020-03-19 · 6y expired

What this patent protects

The present invention relates to carbamoyl phenylalaninol analogs and methods of using the same to treat disorders.

USPTO Abstract

The present invention relates to carbamoyl phenylalaninol analogs and methods of using the same to treat disorders.

Drugs covered by this patent

sodium-oxybate (SODIUM OXYBATE)

Patent Metadata

Patent number: AU2018312328A1
Jurisdiction: AU
Classification: —
Expires: 2020-03-19
Drug substance claim: No
Drug product claim: No
Assignee: Jazz Pharmaceuticals Ireland Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.